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Objective: Little is known about the role of physical activity accumulation in 52 
cardiovascular disease risk for children with type 1 diabetes. Improved insight to identify 53 
factors of influence in key health outcomes could be provided by considering the entire 54 
physical activity profile.  55 
Methods: Pulse wave velocity (PWV), augmentation index and heart rate variability 56 
(HRV) were assessed cross-sectionally in children with (n=29, 12.1 ± 2.1 years) and 57 
without (n=19, 12.1 ± 2.1 years) type 1 diabetes. Time spent sedentary and in each 58 
physical activity intensity, intensity gradient and average acceleration were derived from 59 
seven consecutive days of monitoring with wrist-worn accelerometry. Comparison 60 
between groups and influence of physical activity accumulation on cardiovascular 61 
metrics were explored with linear mixed models.  62 
Results: Diabetic children demonstrated a higher PWV and a greater volume of light 63 
physical activity (p<0.01), a more negative intensity gradient (p<0.01), a lower average 64 
acceleration and less time in bouted moderate-to-vigorous physical activity (MVPA) 65 
(p<0.05). Overall, intensity gradient was strongly correlated with average acceleration, 66 
MVPA and bouted MVPA (r2=0.89, r2=0.80, r2=0.79, respectively; all p<0.05), while 67 
average acceleration was correlated with MVPA and bouted MVPA (r2=0.85, r2=0.83, 68 
respectively; p<0.05). Accounting for disease status, intensity gradient and average 69 
acceleration were significant predictors of HRV indices (p<0.05) and PWV (p<0.01, 70 
p<0.05, respectively).  71 
Conclusion: Overall, MVPA was most associated with central arterial stiffness, 72 
highlighting the importance of meeting activity guidelines. Diabetic children 73 
demonstrated poorer cardiovascular health than their counterparts, likely attributable to 74 
a lower intensity and physical activity volume, identifying physical activity intensity as a 75 
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1. Introduction 83 
Type 1 diabetes, characterised by chronic and lifelong insulin deficiency, is estimated 84 
to affect 400,000 people in the UK, 7.25% of whom are children 1. The most prevalent 85 
cause of mortality in type 1 diabetes is cardiovascular disease (CVD), and individuals 86 
with type 1 diabetes have a four-fold higher risk of developing cardiovascular 87 
complications relative to their non-diabetic peers 2. Pre-clinical indications of this 88 
increased cardiac risk may be evident as early as two years post-diagnosis, 89 
suggesting that those who develop type 1 diabetes early in life have a significantly 90 
increased premature risk of developing CVD, compared with their non-diabetic peers 91 
and those with a later onset 3,4. 92 
 93 
The aetiology of the increased CVD risk in those with type 1 diabetes is suggested, at 94 
least in part, to be related to chronic hyperglycaemia and its deleterious effects on the 95 
vascular and nervous systems caused by increases in oxidative stress and 96 
inflammation 5,6. Vascular dysfunction, which is typically characterised by poor 97 
vascular elasticity and reactivity 7, is a common complication in type 1 diabetes 8,9. 98 
This reduced arterial compliance also potentially exacerbates the direct role of chronic 99 
hyperglycaemia in the autonomic dysfunction often reported in the paediatric diabetic 100 
population 10,11. The consequently impaired control of cardiac rhythm and heart rate 101 
responsiveness, mediated by the autonomic nervous system and measurable through 102 
the indices of heart rate variability (HRV), is associated with an increased risk of short- 103 
and long-term complications, and specifically with an elevated risk of CVD 11,12. 104 
 105 
Physical activity, along with the application of exogenous insulin and the strict control 106 
of diet, is essential for the management of type 1 diabetes and is associated with a 107 





Moreover, research suggests that meeting the UK physical activity recommendations 109 
of, on average, 60 minutes of moderate-to-vigorous physical activity (MVPA) per day 110 
across the week 13, is strongly correlated with additional health-associated benefits for 111 
those with type 1 diabetes 14,15. In children with type 1 diabetes, physical activity 112 
improves glucose control 14,16,17, helps prevent insulin resistance 18-20, reduces 113 
traditional CVD risk factors 19,21,22 and maintains a healthy vascular reactivity 23 and 114 
healthy autonomic function 24-26. However, recent research found that only 39% of 115 
children with type 1 diabetes met the current UK physical activity guidelines 13, with 116 
these children engaging in significantly less MVPA than their non-diabetic peers 27. 117 
 118 
While MVPA is associated with important health benefits, longer durations of light-119 
intensity physical activity (LPA) in healthy children have also been associated with 120 
multiple benefits 28, including a lower stiffness in the small arteries 29,30. This suggests 121 
that all physical activity, irrespective of intensity, can elicit health-associated benefits 122 
and highlights the need to consider the whole physical activity profile. However, 123 
research has predominantly focused on exploring the health influences of the volume 124 
of time spent in different intensities, rather than exploring the overall effect of 125 
accumulated physical activity, irrespective of intensity. Furthermore, this focus on the 126 
volume of physical activity has been almost exclusively based on various cut-points 127 
that were derived from different protocols, segmenting the available data 31 and largely 128 
precluding inter-study comparisons. In contrast, utilising all available movement data 129 
to determine the distribution of physical activity intensity and volume accrued, in the 130 
form of the activity profile, enables the identification of those patterns and variances in 131 
physical activity that are most strongly associated with health outcomes 32. Vitally, 132 
such metrics enable inter-study comparisons 32 and could thereby facilitate the 133 





reducing long-term health complications. Such approaches would be particularly 135 
valuable in a diabetic population, as even relatively small changes can elicit 136 
improvements in disease management, cardiovascular health and quality of life 33. 137 
 138 
The primary aim of the current study was therefore to determine the influence of type 139 
1 diabetes on the accumulation of physical activity in diabetic youths and to determine 140 
whether it is the volume or the intensity of physical activity, or a combination of these, 141 






2. Methods 148 
The present cross-sectional study was conducted in paediatric diabetes clinics and 149 
schools in South Wales, across a 2-year period. Interested participants were referred 150 
by their paediatric diabetic team to the first author for further information. Following 151 
written informed assent and consent from participants and parents/guardians, 152 
respectively, measurements and assessments were taken over a 2-hour testing 153 
period, with physical activity subsequently assessed over seven consecutive days. 154 
The study was approved by a National Health Service (NHS) Research Ethics 155 
Committee (16/NE/0082 195492) and conducted in accordance with the Declaration of 156 
Helsinki. 157 
 158 





29 children with type 1 diabetes (12.1 ± 2.1 years; 14 girls) and 19 without type 1 160 
diabetes (11.8 ± 2.2 years; 6 girls) participated in this study. Potential participants with 161 
any known cardiovascular disease, kidney disease, metabolic disease or hypertension 162 
were excluded. Diabetes-specific exclusion criteria were: a diabetes duration of less 163 
than 1 year; currently being in poor glycaemic control and at an increased risk of 164 
diabetic ketoacidosis (HbA1c ≥80.0 mmol∙mol-1); or identified by the paediatric 165 
diabetes team as otherwise unsuitable for participation in the study.  166 
 167 
2.2 Anthropometric, Maturity and Metabolic Measures 168 
Standing and sitting stature were measured to the nearest 0.1 cm using a Holtain 169 
stadiometer (Holtain, Crymych Dyfed, UK), with body mass measured to the nearest 170 
0.1 kg using electronic scales (Seca 803, Seca, Chino, CA, USA). Body mass index 171 
(BMI) and BMI z-score (BMIz) were subsequently calculated. Data on each 172 
participant’s blood glucose control, lipid profile and HbA1c were obtained from medical 173 
records. Maturity was estimated using sex-specific maturity offset equations in order to 174 
approximate the time in years pre- or post-peak height velocity (PHV). Maturity status 175 
was defined as prepubertal if >1 year pre-PHV, pubertal if 1 year pre- or post-PHV, 176 
and post-pubertal if >1 year post-PHV 34.  177 
 178 
2.3 Habitual Physical Activity Measurements 179 
Participants wore a GENEActiv triaxial accelerometer (GENEActiv, Activinsights Ltd, 180 
Cambridgeshire, UK) sampling at 20 Hz on their right wrist for seven consecutive days 181 
from midnight following the study visit. The GENEActiv has been validated for use in 182 
children 35 and has been shown to be reliable in comparison to other validated 183 





participants were given diaries to monitor sleep quality and duration, and to record 185 
times and reasons for accelerometer removal.  186 
 187 
2.4 Vascular Assessment  188 
Non-invasive assessment of vascular function was carried out employing a cuff-based 189 
osillometric technique (Vicorder, Skidmore Medical, Bristol, UK; D.E.Hokanson Inc, 190 
Bellevue, WA, USA), with the participant in a supine position, torso elevated to 191 
approximately 30o, in a quiet environment and having rested for five-minutes prior to 192 
assessment to ensure stable haemodynamics (heart rate and blood pressure). Pulse 193 
wave analysis (PWA) was completed with a cuff on the upper left arm, at the brachial 194 
artery. A stable blood pressure (BP) was initially obtained to inform the inbuilt 195 
automated protocol, then the pulse-pressure waveform was recorded deriving central 196 
augmentation pressure (AP) and index (AIx) by integral transfer function. Specifically, 197 
AP was calculated as the difference in pressure between peaks one and two on the 198 
systolic waveform and AIx was equal to AP expressed as a percentage of pulse 199 
pressure 37. Aortic stiffness was estimated from the carotid to femoral pulse wave 200 
velocity (PWV), completed by placing a partial cuff over the carotid pulse and a cuff at 201 
the upper thigh, then measuring the distance between the sternal notch and the 202 
middle of the femoral cuff. Carotid and femoral waveforms were then recorded, 203 
deriving PWV in m/s. Three recordings for each process, PWA and PWV, were taken 204 
to obtain at least two congruent measures within 0.5 m/s, 5 mmHg and 5 % of each 205 
other, respectively.  206 
 207 
2.5 Assessment of HRV 208 
A short-term ECG recording, from which RR-intervals can be derived, was obtained 209 





UK), producing 12-bit resolution ECG data at a sampling frequency of 1,024 Hz. Three 211 
electrodes were positioned on the anterior of the torso, at the manubrium of the 212 
sternum and the V5 and V5R positions. Accurate placement of each electrode was 213 
ensured by visually observing each channel prior to recording. A representative 214 
resting measure of autonomic function was obtained by recording for 5-minutes during 215 




2.6 HRV Data Processing 220 
ECG data from the Reynolds CF Holter recorder were exported and processed using 221 
the Reynolds Pathfinder ECG analysis system (Spacelabs Medical Ltd, Hertford, UK). 222 
The pathfinder system classified QRS cycles as either normal (resulting from sinus 223 
node depolarisations) or aberrant, and normal cardiac (RR) interval data were then 224 
extracted using the Reynolds Research Tools software (Spacelabs Medical Ltd, 225 
Hertford, UK). The resulting RR data were visually assessed to identify and delete any 226 
obvious artefacts (those of non-physiological origin). The processed RR data were 227 
then analysed using Kubios HRV V3.0 (Biomedical Signal Analysis Group, 228 
Department of Applied Physics, University of Kuopio, Finland) to derive time-domain, 229 
frequency-domain and geometric indices of HRV. The RR data was initially detrended 230 
using the ‘Smoothn priors’ option, with Lamdba set to 500. Time domain analysis of 231 
the RR data yielded RMSSD (the square root of the mean of the sum of the squares 232 
of differences between adjacent RR intervals), a short-term measure indicative of 233 
parasympathetic activation 38. Frequency domain indices were spectrally estimated by 234 
Welch’s method of power spectral density estimation and autoregressive modelling 235 





0.15-0.40 Hz) bands. These indices were then expressed in both absolute and relative 237 
terms following normalisation to total spectral power (TSP; 0.04-0.40 Hz). HF was 238 
included as an indication of parasympathetic activity, while LF can be both an 239 
indication of parasympathetic/sympathetic balance and sympathetic activation 38. The 240 
geometric indices derived were SD1 and SD2 (the standard deviations of short-term 241 
and long-term variations in RR, respectively), which were determined from the axes of 242 
the Poincaré plot 38.  243 
 244 
2.7 Habitual Physical Activity Data and Analysis 245 
Raw accelerometer data were extracted using the GENEActiv PC software v2.2 246 
(Activinsights Ltd, Cambridgeshire, UK). Signal processing was subsequently 247 
completed with R software (https://cran.r-project.org) using the GGIR package 248 
(https://cran.rproject.org/web/packages/GGIR/vignettes/GGIR.html) to convert the 249 
triaxial acceleration values to an omnidirectional acceleration in the form of the signal 250 
vector magnitude (SVM). Raw acceleration values were processed by the ‘Euclidian 251 
norm minus one’ (ENMO) method 39, then reduced to 5 second epochs and expressed 252 
in milligravity-based acceleration units (mg) 40. Minimum wear-time was classified as 253 
≥16 hours during waking hours, defined as 0600 to 2300, over three weekdays and 254 
one weekend day 41. Hildebrand et al.’s raw acceleration thresholds 42 were utilised to 255 
determine the time spent in different intensity domains (<50 mg for sedentary time 256 
(ST), 50-99 mg for light physical activity (LPA), ≥100 mg for MVPA; 40). Tolerance 257 
thresholds for LPA and MVPA bouts were set as ≥10 minutes of continuous 5s 258 
epochs, where 80% of epochs were ≥ 50 or ≥ 100 mg, respectively 43. Bouted time 259 
was presented as an average of the included participants and valid days, therefore 260 
depending on engagement in bouts by participants the average can be below the set 261 





nocturnal sleep algorithm as no arm angle change > 5o for ≥ 5 minutes. Total 263 
movement was quantified as the average acceleration over a 24-hour period 31. 264 
 265 
The intensity gradient, a metric of physical activity intensity distribution 32, was 266 
calculated for each participant. Specifically, the curvilinear relationship between 267 
intensity and time spent in in each successive 25 mg time bin between 0 and 4,000 268 
mg was transformed to a linear relationship using the natural log of each variable. The 269 
R2 value obtained indicated the goodness of fit of the linear model, whilst the gradient 270 
and constant of the linear regression represented the activity distribution. A higher 271 
constant and a more negative gradient represent a steeper decline and therefore less 272 
time accumulated at mid-to-high intensities. Conversely, a lower constant and a less 273 
negative gradient represents a shallower drop and is therefore indicative of more time 274 
spread across the intensities 32.  275 
 276 
2.8 Statistical analysis 277 
The SPSS software package (IBM SPSS Statistics for Macintosh, Version 22.0) was 278 
used to perform statistical analyses, with significance set as p<0.05 and all data 279 
expressed as mean ± SD. Initially, independent t-tests were used to compare included 280 
and excluded participants and to assess participant characteristics according to group 281 
(children with and without diabetes). Linear mixed models with a random intercept 282 
were then conducted to compare physical activity metrics between children with and 283 
without type 1 diabetes. Separate models were constructed with model 1 only 284 
including the physical activity metrics, and model 2 adjusted for age, sex, maturation 285 
and BMI. The final model was further adjusted for the alternative metric (intensity 286 
gradient or average acceleration) to test the independence between volume and 287 





association between the intensity gradient, average acceleration, MVPA and bouted 289 
MVPA, and to ascertain whether the intensity gradient showed greater independence 290 
to average acceleration than MVPA or bouted MVPA. Finally, both samples were 291 
pooled and linear mixed modelling with random intercept was utilised to explore the 292 
associations between the volume/intensity of physical activity and measures of 293 
cardiovascular function and control. Model 1 adjusted for clustering of disease status, 294 
whereas model 2 was adjusted for disease status, age, sex and maturity, and model 3 295 
was further adjusted for the alternative physical activity metric (intensity gradient or 296 
average acceleration) to assess for an independent effect.  297 
 298 
3. Results 299 
Following the exclusion of eight participants (n=6 type 1 diabetes, due to failed 300 
calibration and failing to meet the wear-time criteria; n=2 controls, due to failing to 301 
meet wear-time criteria), the final sample consisted of 40 participants (23 type 1 302 
diabetes, 17 non-diabetic). There were no significant differences between those 303 
included or excluded with regards to age, anthropometric measures or maturity (data 304 
not shown). Participant descriptive characteristics and physical activity outcomes are 305 
presented in Table 1. Participants with type 1 diabetes were observed to have HbA1c 306 
levels greater than the NICE recommended level of 48 mmol∙mol-1 (above which the 307 
risk of developing long-term complications is significantly increased) 45. 308 
 309 
**Insert Table 1 here** 310 
 311 
Multiple mixed model analyses highlighted significant differences in the intensity 312 
gradient (p<0.01), average acceleration (p<0.05) and time spent in LPA (p<0.05) for 313 





BMI (Table 2). There were no significant differences in MVPA (p>0.05), bouted MVPA 315 
(p=0.058), bouted LPA (p>0.05) or ST (p>0.05) between the two groups. Amongst the 316 
boys, those without diabetes showed the highest average acceleration and highest 317 
intensity gradient but the lowest LPA; amongst the girls, those with diabetes 318 
demonstrated the lowest LPA, lowest intensity gradient and lowest average 319 
acceleration. 320 
 321 
Intensity gradient was strongly associated with both MVPA and bouted MVPA (r=0.80, 322 
p<0.01; r=0.79, p<0.01, respectively), but less strongly correlated with sedentary time 323 
(r=-0.36, p<0.05). Average acceleration was similarly strongly correlated with both 324 
intensity gradient and cut-point metrics. Specifically, average acceleration was 325 
correlated with the intensity gradient (r=0.89, p<0.01), MVPA (r=0.85, p<0.01) and 326 
bouted MVPA (r=0.83, p<0.01), while only moderately correlated to sedentary time 327 
(r=-0.36, p<0.05). Intensity gradient and average acceleration showed no significant 328 
correlation with LPA or bouted LPA.  329 
 330 
**Insert Table 2 Here** 331 
 332 
Cardiovascular outcomes for both groups are presented in Table 3. Modest negative 333 
correlations were observed between PWV and intensity gradient (r2=-0.38, p<0.05), 334 
average acceleration (r2=-0.40, p<0.05), MVPA (r2=-0.43, p<0.05) and bouted MVPA 335 
(r2=-0.45, p<0.05). Average acceleration was also modestly correlated to resting 336 
absolute LF (r2=0.44, p<0.05) and TSP (r2=0.43, p<0.05). Neither intensity gradient 337 
nor average acceleration were significantly correlated to AIx, augmentation pressure 338 






**Insert Table 3 Here** 341 
 342 
The association between physical activity metrics and measures of cardiovascular 343 
function are presented in Table 4. Both intensity gradient and average acceleration 344 
were significant predictors of PWV, RMSSD, LF, total spectral power and SD1 when 345 
unadjusted, but not when adjusted for covariates. 346 
 347 
**Insert Table 4 Here** 348 
 349 
4. Discussion 350 
This is the first study to explore physical activity in children with type 1 diabetes using 351 
more novel, intensity-based, rather than conventional volume-based, measures to 352 
consider how physical activity is accumulated. Moreover, this study sought to 353 
investigate whether these metrics differ according to disease status and health 354 
outcomes. The key findings from the study were: (i) children with type 1 diabetes 355 
engaged in significantly less higher intensity physical activity than their non-diabetic 356 
peers; (ii) intensity gradient was not independent of average acceleration or MVPA; 357 
(iii) type 1 diabetic children had a poorer (higher) PWV and short-term HRV tended to 358 
be decreased compared to their non-diabetic peers; and (iv) intensity of physical 359 
activity was most strongly associated with a more favourable PWV and HRV indices.  360 
 361 
Physical activity is known to be associated with numerous short- and long-term health 362 
benefits in children 46, as well as in the management of type 1 diabetes 17. In 363 
accordance with previous research 47,48, the current study found that children with type 364 
1 diabetes typically undertake less MVPA than their non-diabetic peers. Indeed, 365 





lower volume of MVPA because of a lack of understanding about how to compensate 367 
for different types and intensities of exercise, and due to a fear of subsequent 368 
hypoglycaemia 49. However, whilst conventional, volume-based measures of physical 369 
activity have been extensively researched in the paediatric diabetic population, little is 370 
known regarding the physical activity profile as a whole. The current study therefore 371 
extends these earlier studies, demonstrating that diabetic children have a steeper, 372 
less favourable, intensity profile and lower average acceleration than their non-373 
diabetic peers. These findings indicate that diabetic participants engaged in 374 
significantly more LPA than MVPA and moved less at higher intensities compared to 375 
their non-diabetic peers. Whilst these findings highlight LPA as a potential target for 376 
interventions, with suggestions that targeting LPA may represent a more feasible and 377 
sustainable target than MVPA for those with low physical activity levels at baseline 378 
50,51, it is worth noting that the greatest health benefits are elicited through MVPA, with 379 
significantly longer periods of LPA required to obtain similar benefits 52. Therefore, 380 
future studies in children with chronic diseases should utilise the activity profile to gain 381 
a greater insight into the accumulation of physical activity, to facilitate an accurate 382 
comparison of physical activity patterns between populations, and to identify key 383 
targets for intervention.  384 
 385 
Previous studies in healthy children found that the intensity gradient was associated 386 
with conventional volume-based metrics, independent of average acceleration 31,32. 387 
The strongest association in these studies was demonstrated between the intensity 388 
gradient and MVPA, suggesting that the intensity gradient best represents more 389 
vigorous intensity physical activity 31,32. In contrast, time spent in MVPA in the current 390 
sample was similarly correlated with both the intensity gradient and average 391 





gradient was not independently associated with conventional cut-points, a finding in 393 
contrast with previous literature. This lack of independence from MVPA might 394 
therefore limit the ability to explore the relative importance of physical activity volume 395 
and intensity in cardiovascular health 53. Such discrepancies might be partially due to 396 
the high volume of physical activity in which both populations engaged, which could 397 
mask the importance of intensity. Alternatively, accelerometer wear-location is thought 398 
to influence the magnitude of average acceleration, possibly resulting in increased 399 
variance in intensity gradient 32. 400 
 401 
Research has suggested that physical activity slows the progression of premature 402 
arterial stiffening in children with type 1 diabetes, thereby reducing the risk of long-403 
term complications later in life 54,55. Congruent with previous research 56, significant 404 
differences were observed in PWV, with diabetic children presenting a 10% higher 405 
PWV than their non-diabetic peers. This difference may indicate premature central 406 
stiffening, a likely indicator of increased long-term CVD risk. Furthermore, negative 407 
associations were observed, irrespective of disease status, between PWV and 408 
intensity gradient, average acceleration, MVPA and bouted MVPA, but not LPA. Thus, 409 
a more positive or shallow gradient, indicative of engagement in more vigorous 410 
intensities, and a higher average acceleration, suggesting higher volumes of physical 411 
activity were associated with a lower PWV. Such findings suggest that higher volumes 412 
and a greater engagement in more vigorous intensities of physical activity positively 413 
influenced central stiffness. Additionally, the steeper gradient, lower average 414 
acceleration and the lower volume of MVPA, observed in this diabetic sample, 415 
suggests that the volume and intensity undertaken might not be sufficient to 416 
ameliorate the negative changes in central stiffening. Therefore, these findings further 417 





vigorous intensity physical activity, in order to slow the progression of disease-related 419 
central arterial stiffening.  420 
 421 
Previous research has demonstrated that children with type 1 diabetes who participate 422 
in lower volumes of physical activity have significantly lower HRV at rest, than more 423 
physically active participants with and without diabetes 24. The clinical sample in the 424 
current study participated in significantly lower volumes of physical activity and 425 
showed non-significant, but characteristically lower values for absolute HF, total 426 
power, RMSSD and SD1, in comparison to their healthy controls. Lower magnitudes 427 
of total power, RMSSD, HF and SD1 in the short-term can indicate reduced overall 428 
cardiac autonomic activity, particularly of the parasympathetic (vagally-mediated) 429 
neural control of heart rate 38. This suggests a possible shift towards systemic 430 
autonomic dysfunction that may increase the risk of developing autonomic 431 
neuropathy, a common complication in type 1 diabetes 57. However, a positive 432 
association between physical activity intensity/volume and cardiac autonomic function, 433 
across both populations in this study, suggests that both intensity and volume could 434 
positively influence age- and disease-related decline in autonomic function 26,58. 435 
Specifically, attaining a greater volume of physical activity, represented by a greater 436 
average acceleration, and accruing more vigorous intensities of physical activity were 437 
both associated with greater overall autonomic activity and vagal tone, therefore 438 
suggesting a potentially reduced risk of developing autonomic neuropathy. 439 
Furthermore, increased autonomic activity and vagal tone has been found to be a 440 
predictor of central arterial stiffness, a pre-clinical indicator of CVD in type 1 diabetes 441 
59, as observed in the current study. Thus, taken together, physical activity of sufficient 442 
volume and intensity may ameliorate age- and disease-related declines in autonomic 443 






There are numerous strengths associated with the current research, not least the use 446 
of recently devised physical activity metrics to explore how disease status influences 447 
physical activity accumulation. Nonetheless, this study is not without limitations, such 448 
as the sample size and sex distribution within the samples, which could limit the 449 
generalisability of the results. Furthermore, the potential presence of a Hawthorne 450 
effect should be considered when interpreting the current results 60. However, the 451 
metrics utilised facilitate inter-study comparisons, potentially enabling the use of this 452 
data in larger cohort analyses.  453 
 454 
In conclusion, this study demonstrated that the accumulated daily volume of vigorous 455 
intensity physical activity has the greatest influence on arterial stiffening and cardiac 456 
autonomic function, both of which are indicators of CVD risk for children with type 1 457 
diabetes. Therefore, future physical activity interventions should focus on increasing 458 
the intensity of physical activity undertaken by this population. Children with type 1 459 
diabetes demonstrated significantly increased in central arterial stiffness and impaired 460 
cardiac in autonomic function, compared to those without diabetes. Finally, quantifying 461 
intensity gradient and average acceleration enabled the identification of overall 462 
physical activity accumulation, which is important in preventing long-term risk of CVD 463 
in this population.  464 
 465 
Data Availability 466 
The datasets generated during and/or analysed during the current study are available 467 
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Table 1 – Participant characteristics  635 




Age (yrs) 12.1 (2.1) 11.8 (2.2) 
BMI (kg∙m-2) 20.7 (3.7) 19.3 (4.1) 
BMIz 0.87 (1.03) 0.43 (1.21) 
Maturity offset (yrs) -1.55 (1.65) -1.30 (2.04) 
Sedentary time (mins∙day-1) 492.0 (119.4) 527.8 (101.3) 
LPA (mins∙day-1) 471.0 (61.6)** 410.9 (71.5) 
Bouted LPA (mins∙day-1) 166.4 (66.0) 148.0 (63.6) 
MVPA (mins∙day-1) 82.9 (37.2) 114.0 (72.1) 
Bouted MVPA (mins∙day-1) 4.5 (4.7)* 12.9 (15.3) 
Average acceleration (mg) 37.2 (9.7)* 46.2 (18.1) 
Intensity gradient -2.11 (0.18)** -1.90 (0.23) 
Intensity constant 13.02 (0.66)** 12.36 (0.76) 
Intensity R2 0.84 (0.05) 0.86 (0.05) 
Sleep efficiency (%) 82.9 (11.0) 83.1 (11.5) 
HbA1c (mmol∙mol-1) 68.24 (12.14) - 
HbA1c (%) 8.4 (1.1) - 
Total- C (mmol∙l-1)  4.22 (0.39) - 
LDL-c (mmol∙l-1) 2.30 (0.33) - 
Disease duration (yrs) 5.0 (3.2) - 
Values are presented as mean (SD).  636 
Body mass index (BMI), Sedentary time (ST), Light physical activity (LPA), Moderate-637 
to-vigorous physical activity (MVPA) 638 
Glycated haemoglobin (HbA1c), Total cholesterol (Total-C), Low density lipoprotein 639 
(LDL-c) 640 






Table 2 - Linear mixed model of between-group differences in activity metrics and 643 
disease status 644 





95% CI β 
 





-0.22** -0.35, -0.08 -0.19** -0.33, -0.05 -0.13* -0.25, -0.02 Y 
Intensity 
constant 




-9.58* -19.07, -0.10 -4.67 -11.84, 2.49 2.08 -3.77, 7.94 X 
Sedentary time 
(mins∙day-1) 
-35.8 -111.1, 39.5 -36.4 -110.8, 38.0 -63.2 -141.7, 15.3 Y 
LPA (mins∙day-1) 60.1** 15.1, 105.1 63.5** 8.5, 108.4 74.7** 26.3, 123.1 Y 
Bouted LPA 
(mins∙day-1) 
18.5 -25.5, 62.4 10.4 -33.1, 54.0 19.9 -27.2, 67.0 Y 
MVPA 
(mins∙day-1) 
-31.2 -69.4, 7.1 -12.6 -44.3, 19.1 0.6 -32.3, 33.6 X 
Bouted MVPA 
(mins∙day-1) 
-8.3* -15.8, -0.8 -6.3 13.3, 0.7 -0.9 -7.0, 5.3 Y 
Model 1 unadjusted model grouped with disease status, model 2 adjusted for potential 645 
covariates: age, sex, maturity status, BMIz, model 3 adjusted for covariates and 646 
alternative physical activity metric to determine if independent (average acceleration 647 
for intensity gradient, intensity gradient for all other metrics), with an independent and 648 
non-independent relationships denoted by Y and X, respectively. 649 
Light physical activity (LPA), moderate to vigorous physical activity (MVPA) 650 





Table 3 – Measures of cardiovascular function for diabetic and non-diabetic 652 
participants 653 




Resting blood pressure 
(mmHg) 
114/60 116/62 
MAP (mmHg) 83.5 (6.6) 84.9 (5.4) 
Augmentation pressure 
(mmHg) 
7 (4) 8 (4) 
Augmentation index (%) 13.52 (6.47) 15.25 (7.02) 
Pulse wave velocity (m/s) 5.04 (0.66)** 4.58 (0.70) 
Heart rate variability:   
TSP (ms2) 3291 (3982) 5060 (7308) 
LF (ms2) 1309 (1217) 2204 (2720) 
HF (ms2) 1917 (2806) 2715 (5283) 
LF (n.u) 50.9 (16.9) 53.1 (14.0) 
HF (n.u) 49.0 (16.9) 46.7 (14.0) 
RMSSD (ms) 53.5 (32.1) 65.2. (52.3) 
    SD1 (ms) 37.9 (22.7) 46.1 (37.1) 
    SD2 (ms) 67.3 (26.6) 78.4 (45.6) 
   
Values are presented as mean (SD).  654 
Mean arterial pressure (MAP), total spectral power (TSP), Low frequency (LF), High 655 
frequency (HF), Root mean square of the successive differences of RR (RMSSD), 656 
standard deviations of the Poincare plot 1 and 2 (SD1and SD2). 657 







Table 4 - Associations between physical activity metrics and measures of 661 
cardiovascular function and control for the overall study population 662 
 Model 1 Model 2 Model 3 Independent 
(model 3)  β 
 
95% CI β 
 
95% CI β 
 
95% CI 
PWV        
Intensity gradient -1.62** -2.82, -0.42 -1.27 -2.77, 0.23 -1.27 -3.56, 1.02 Y 
Average acceleration -0.02* -0.04, -0.004 -0.01 -0.03, 0.01 -0.00 -0.03, 0.03 X 
Augmentation pressure        
Intensity gradient -2.23 -9.25, 4.78 3.14 -6.32, 12.61 -7.03 -20.54, 6.48 X 
Average acceleration 0.01 -0.08, 0.10 0.10  -0.01, 0.22  0.17  -0.00, 0.34  Y 
Augmentation index        
Intensity gradient -1.26 -13.30, 10.78  8.14 -8.09, 24.37  -5.79 -29.55, 17.97  X 
Average acceleration 0.03 -0.13, 0.19  0.18 -0.02, 0.37  0.23 -0.07, 0.53 Y 
MAP        
Intensity gradient 10.53 -0.45, 21.51 5.96 -8.14, 20.05 11.31 -10.05 ,32.66 Y 
Average acceleration 0.10 -0.04, 0.25 0.02 -0.16, 0.20 -0.10 -0.36, 0.18 X 
RMSSD        
Intensity gradient 78.0* 1.8, 154.3 44.4 -74.6, 163.3 16.1 -148.3, 180.4 Y 
Average acceleration 1.1* 0.1, 2.2 0.7 -0.9, 2.3 0.6 -1.7, 2.8 Y 
LF        
Intensity gradient 4,403* 759, 8,046 1,822 -3,777, 7421 -1,634 -9,171, 5,903 X 
Average acceleration 73** 25, 120 53 -22, 127 68 -35, 172 Y 
HF        
Intensity gradient 6,333 -1,245, 13,910 3,776 -8,127, 15,680 2,681 -13,713, 19,075 Y 
Average acceleration 82 -22, 186 43 -119, 205 20 -204, 245 Y 
TSP        
Intensity gradient 11,025* 742, 21,309 5,440 -10,550, 21,448 978 -21,091, 23,047 Y 
Average acceleration 158* 19, 298 98 -120, 316 88 -214, 391 Y 
SD1        
Intensity gradient 55.3* 1.3, 109.3 31.5 -52.7, 115.7 11.4 -105.0, 127.8 X 
Average acceleration 0.8* 0.055, 1.5 0.5 -0.6, 1.7 0.4 -1.2, 2.0 Y 
SD2        
Intensity gradient 73.9* 9.7, 138.0 29.1 -71.1, 129.3 1.6 -136.7, 139.8 X 
Average acceleration 1.1* 0.2, 1.0 0.6 -0.8, 1.9 0.5 -1.4, 2.4 X 
Model 1 unadjusted model; model 2 adjusted for potential covariates: age, sex, and 663 
maturity status; model 3 adjusted for covariates and alternative physical activity metric 664 
to determine if independent. 665 
95% confidence interval (CI), Pulse wave velocity (PWV), Mean arterial pressure 666 





(LF), High frequency (HF), Total spectral power (TSP), standard deviations of the 668 
Poincare plot 1 and 2 (SD1 and SD2) 669 
Significant prediction between independent and dependent variable *p<0.05, **p<0.01 670 
 671 
